Barclays

Like the film of the same name, investment bank 'matrix' structures make GlobalCapital’s head hurt, and become tedious when they’re repeated a few times. Trying to decipher which banker is responsible for which business becomes a complex head-scratcher. One imagines revenue-credit discussions are similarly painful.

Thames Water priced a £300m senior secured no-grow bond on Thursday, clinching the deal after two weeks of volatility in its outstanding bonds.

Macquarie issued its inaugural covered bond on Thursday, meeting a strong reception with the five year €500m paper twice subscribed by investors. Westpac has also opened books on a $1.35bn deal, as Fitch said it expects Australian covered bond issuance to rise this year.

US biotechnology company Amgen made its dash into primary corporate bond markets on Thursday with a dual tranche deal that took €2bn out of the market.

Marcel Koebeli, the country head of Switzerland at Barclays, has left the bank.

High yield bankers insist that the European market will not be paralysed by some of the banks holding debt they have been unable to sell, even after the failure of last week's €1.55bn financing for LeasePlan.

Barclays has announced a swathe of debt capital markets promotions, several new desk heads, and a new structure for EMEA, following last week's changes to the DCM management team.

FMS-Wertmanagement increased the size of a dollar floating rate note on Tuesday after receiving strong demand, and more floaters could follow as bankers report growing interest in the format from central banks.

Pendragon, the UK car dealer, has refinanced its debt, issuing a private placement and signing a new unsecured club revolving credit facility that cut its margin by a hefty 85bp.

Mexico is looking to sell its fifth euro denominated bond in four years after releasing initial price thoughts for six and 15 year tranches on Tuesday.

HoneyWell International took the earliest possible moment to issue its first euro denominated bond since 2001, bringing a €4bn four tranche offering to market.

Delta Lloyd, the Dutch insurance company, is facing opposition to its planned €1bn rights issue - more than the company is now worth - from as many as a third of its shareholders.